Open-label Phase 2 trial in breast cancer to begin this quarter
Initial data expected mid-2025
https://www.globenewswire.com/news-release/2024/07/30/2920968/0/en/Processa-Pharmaceuticals-Announces-FDA-Clearance-of-IND-Application-for-a-Phase-2-Clinical-Trial-of-NGC-Cap-in-Breast-Cancer.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.